We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£145.80
It has never been this cheap. We have no record of a lower price.
£146 today · cheaper than every other day in the last 3 months
Elsevier Cytokine-Based Immunotherapy Part B Volume 401 - Medical Review
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 71 days · 71 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 71 days • 1 price levels
Price Analysis
Most common price: £146 (71 days, 100.0%)
Price range: £146 - £146
Price levels: 1 different prices over 71 days
Description
Key Features
Volume 401 of the International Review of Cell and Molecular Biology series provides peer-reviewed research on cytokine signalling in immunotherapy.
Chapters address cytokine-based immunotherapy applications specifically in pancreatic cancer treatment and outcomes.
Explores IL-33 and its diverse biological roles in cancer development and immune regulation.
Examines immunocytokines derived from IL-12 for enhancing cancer therapy efficacy whilst reducing adverse effects.
Published by Academic Press, a leading authority in biomedical and life sciences educational resources.
Product Specifications
- Brand
- Elsevier
- Format
- hardcover
- ASIN
- 044341761X
- Domain
- Amazon UK
- Release Date
- 09 June 2026
- Listed Since
- 12 November 2025
Barcode
No barcode data available
Similar Products You Might Like
Immuno-oncology and Immunotherapy Part C - Volume 191
Elsevier
Immuno-oncology and Immunotherapy Part A - Volume 189
Elsevier
Academic Press Immuno-oncology and Immunotherapy Vol 190
Elsevier
Immuno-oncology and Immunotherapy Part F: Volume 201 (Methods in Cell Biology, Volume 201)
Elsevier
Immuno-oncology and Immunotherapy Part G: Volume 202 (Methods in Cell Biology, Volume 202)
Elsevier
Academic Press Cell-based Cancer Immunotherapy Vol 183
Elsevier
T Cell Metabolism and Cancer Immunotherapy - Academic Press
Elsevier
Immuno-oncology and Immunotherapy Part D - Volume 196
Elsevier
Cancer Immunotherapy (Volume 209) (Progress in Molecular Biology and Translational Science, Volume 209)
Elsevier
Immuno-oncology and Immunotherapy Part E - Volume 199
Elsevier
Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies: 183 (Cancer Treatment and Research, 183)
Springer
Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies: 183 (Cancer Treatment and Research, 183)
Springer
Academic Press - Anti-CD20 Antibody Resistance Volume 2
Elsevier
Frontiers in Cancer Immunology; Systems Biology in Cancer Immunotherapy: 2
Bentham Science Publishers
Cancer Immunotherapy in Clinical Practice - Medical Textbook
McGraw-Hill Education
Immunomodulators - Part A (Volume 151) (Advances in Protein Chemistry and Structural Biology, Volume 151)
Elsevier
Advances in DNA and mRNA Cancer Immunotherapy - Volume 165
Elsevier
Advances in Immunology: Volume 155
Elsevier
Immunothérapie des cancers au troisième millénaire
EDP SCIENCES
Immunotherapy: Magic Bullet to Change the Future Therapeutics: Volume 144 (Advances in Protein Chemistry and Structural Biology, Volume 144)
Elsevier
Immunobiology of COVID-19 (Volume 202) (Progress in Molecular Biology and Translational Science, Volume 202)
Elsevier
Cancer Immunotherapy - Cellular Mechanisms & Therapeutic Advances
IntechOpen
Principles of Immunotherapy in Breast and Gastrointestinal Cancers: Activity, Mechanisms of Resistance and New Sensitization Strategies (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)
Elsevier
Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)
Humana